pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
RG1005296
Phase 2 mab active
Quick answer
pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine for Anatomic Stage I Breast Cancer AJCC v8 is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Anatomic Stage I Breast Cancer AJCC v8
- Phase
- Phase 2
- Modality
- mab
- Status
- active